ESR1 and breast carcinoma: The group of genes identifying Luminal-type breast cancer is highly enriched for genes having an estrogen receptor (ER) binding site proximal to the promoter region, suggesting that these genes are direct targets of the ER.7 MammaPrint combined with BluePrint can substratify luminal subtype patients into Luminal A and Luminal B groups.